Category Archives: Uncategorized

Founder Laura Hales speaks on a panel sponsored by The Capital Network

At an event titled “SBIR – America’s Largest Seed Fund”, Extend Biosciences founder Laura Hales spoke about her experience winning SBIR grants.

See event details here ->

A Panel on Women Entrepreneurs in STEM features founder Laura Hales

Founder Laura Hales was one of four female entrepreneurs featured on a panel titled “She Prevailed – The Secretes to Start-up Success in STEM from Women Entrepreneurs”. The panel was sponsored by AWIS and also featured Patrice Milos, Ailis Tweed-Kent, and Teresa Nelson, and was moderated by Joanne Kamens.

See event details here ->

Extend Biosciences is awarded a Phase II SBIR grant from NCI

Extend Biosciences was awarded a Phase II SBIR grant from the National Cancer Institute to fund efficacy and IND-enabling studies for a long-acting ghrelin molecule for cancer cachexia.

Extend Biosciences has been awarded a third patent

Extend Biosciences’ third patent has been awarded by the USPTO. The patent, titled “Insulin Vitamin D Conjugates” issued April 11, 2017 (US 9,616,109). 

Founder Laura Hales wins the WIB Lobster Pot pitch competition

In a Shark Tank-style event sponsored by Women In Bio, Extend Biosciences founder Laura Hales, Ph.D. won first prize (an All-Clad Lobster Pot!) in the pitch competition in front of >100 audience members and 4 investors.  The event, held at LabCentral, featured 6 companies pitching from life sciences and healthcare, and was moderated by Marian Nakada of JJDC.

See event details here ->

Extend Biosciences is awarded a Phase I grant from NIAID

Extend Biosciences was awarded a Phase I SBIR grant from the National Institute of Allergy and Infectious Disease to work on a program for acute radiation syndrome.

Extend Biosciences says goodbye to LabCentral

Extend Biosciences has completed their 3-year maximum stay at LabCentral and said goodbye to fellow residents and staff at a happy hour in the playroom with Advirna. On February 1, Extend Bio will move to a shared laboratory facility in Newton.

See the post on Twitter->

Extend Biosciences’ Founder Laura Hales Speaks on a Panel on Women in STEM at a Regional SBIR Conference

Laura Hales, Cofounder of Extend Biosciences, spoke about her journey in biotech and entrepreneurship and path to successfully obtaining SBIR funding on a panel on October 5. The panel was moderated by Esther Morales, Executive Director of the National Women’s Business Council, and included Barbara Fox, PhD, Marian Nakada, PhD, and Joanne Kamens, PhD. The title of the panel was “It’s All of Our Business: Succeeding as a Woman in STEM” and was part of the preconference to the 2016 SBIR New England Regional Summit at MIT.

Extend Biosciences Featured in the NSF Innovation Zone at BIO2016

Extend Biosciences was featured in the NSF Innovation Zone at the BIO International Convention 2016 in San Francisco, CA.  The company received complimentary passes to the Convention, and the technology was showcased at the company’s kiosk in the Innovation Zone with a poster and a pitch presentation by CEO Tarik Soliman.

Read the press release here->

Extend Biosciences has been Awarded a Second Patent with Broad Claims

Extend Biosciences’ second patent has been awarded by the USPTO. The patent, titled “Carriers for Improved Drug Delivery” issued March 22, 2016 (US 9,289,507). The patent includes broad claims for the use of vitamin D to improve the pharmacokinetic properties of therapeutic entities.